[The diagnostic value of the assay of lactate dehydrogenese combined with other tumor markers in ovarian cancer].
Thirty-five cases of ovarian cancer, 35 ovarian benign tumors, 31 other gynecologic cancer and 35 normal controls were assayed for LDH, LDH-isoenzyme, SA, CEA, beta 2-MG and AKP. The results showed: (1) The average content of tumor markers in ovarian cancer was higher than benign tumor and healthy controls. (2) The positive rate of tumor markers in stage I and II patients of ovarian cancer was lower than in stage III and IV. (3) In the tumor markers, the diagnostic value of LDH-isoenzyme for ovarian cancer was best. (4) Combined assaying LDH, LDH-isoenzyme and SA was superior to using one marker for the diagnosis of ovarian cancer.
Tang
B J
BJ
Affiliated Tumor Hospital of Guangxi Medical University, Nanning.
Li
L
L
Xu
J
J
D000293:Adolescent; D000328:Adult; D000368:Aged; D014408:Biomarkers, Tumor / Q000097:blood*; D002272:Carcinoembryonic Antigen / Q000097:blood; D005260:Female; D006801:Humans; D007527:Isoenzymes; D007770:L-Lactate Dehydrogenase / Q000097:blood*; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000175:diagnosis*; D012794:Sialic Acids / Q000097:blood
D014408:Biomarkers, Tumor; D002272:Carcinoembryonic Antigen; D007527:Isoenzymes; D012794:Sialic Acids; D007770:L-Lactate Dehydrogenase